fda glp-1 compounding crackdown news The FDA's Continues: What to Know FDA GLP-1 Compounding Crackdown

Since GLP-1 medications themselves can cause gastrointestinal side effects including nausea and altered bowel habits, individuals without a gallbladder may experience a compounding effect that requires careful dietary management and potentially slower dose titration according to the product's SmPC guidance

Some GLP-1 receptor agonists have demonstrated cardiovascular benefits in high-risk populations

Iran J Basic Med Sci 22(3):225 Khandelwal P, Wadhwani BD, Rao RS, Mali D, Vyas P, Kumar T, Nair R (2024) Exploring the pharmacological and chemical aspects of pyrrolo-quinazoline derivatives in Adhatoda vasica

Will my taste buds ever go back to normal

These tell you what extra steps are required before coverage kicks in

With brand-name medications like Ozempic and Wegovy facing persistent supply shortages and carrying premium price tags, millions of patients are turning to licensed compounding pharmacies for affordable, high-quality alternatives